“What the HSCI has done for me was to make me think beyond the mouse.” Andrew McMahon uses stem cell technology to study human kidney development. He was leader of the HSCI Kidney Program before leaving Harvard to take a leadership role at the Broad Center for Regenerative Medicine in Los Angeles, California.
